Sleisenger and Fordtran's Gastrointestinal and Liver Disease - 2 Volume Set
Pathophysiology, Diagnosis, Management
12. Auflage
Churchill Livingstone
ISBN 978-0-443-11657-5
Standardpreis
Bibliografische Daten
Buch
12. Auflage. 2025
In englischer Sprache
Format (B x L): 21,6 x 27,6 cm
Gewicht: 450
Verlag: Churchill Livingstone
ISBN: 978-0-443-11657-5
Produktbeschreibung
- New and expanded discussions of eosinophilic disorders, MASLD (metabolic dysfunction-associated steatotic liver disease, formerly known as non-alcoholic fatty liver disease); the use of AI in endoscopy for improved detection of GI cancers; new treatments for viral hepatitis and autoimmune liver diseases; the expanded array of new treatments for inflammatory bowel disorders; and more
- New chapters on Gastrointestinal and Hepatic Manifestations of Coronavirus Infection; Enterocolitis and Hepatitis Induced by Cancer Immunotherapy, and a new section on Neoplasia Involving Multiple Organs
- Reliable coverage of a wide range of endoscopic procedures for diagnosis and treatment, including balloon dilatation, stent placement/removal, and the management of small bowel angioectasia
- Quick-reference algorithms that summarize clinical decision making and practical approaches to patient management
- A consistent, templated format throughout the text that enables quick retrieval of information, and more than 20 videos of endoscopic procedures
- An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.
TBD at May 2022 planning meeting
Autorinnen und Autoren
Produktsicherheit
Derzeit sind keine Informationen zur Produktsicherheit verfügbar. Wir arbeiten daran, diese Informationen in naher Zukunft für Sie bereitzustellen.